Results 11 to 20 of about 10,778 (201)

Risk of infection in adult patients with primary immune thrombocytopenia (ITP):a systematic review [PDF]

open access: yes, 2021
Introduction: Primary immune thrombocytopenia (ITP) is a bleeding disorder characterized by autoimmune destruction and impaired production of platelets. Immunosuppressive drugs are the main treatment and may increase risk of infection.
Frederiksen, Henrik   +3 more
core   +1 more source

Púrpura trombocitopénica asociado a infección por Covid-19. [PDF]

open access: yes, 2023
The current pandemic of coronavirus disease (COVID-19), produced by a mutant strain of coronavirus SARS-CoV-2, has a predilection for the respiratory tree, once it penetrates it generates an abnormal inflammatory immune response with an increase in ...
Anchundia Macías, Lissette Mercedes   +2 more
core   +5 more sources

Pediatric-onset Evans syndrome: Heterogeneous presentation and high frequency of monogenic disorders including LRBA and CTLA4 mutations [PDF]

open access: yes, 2018
Evans syndrome (ES) is defined by the combination of autoimmune hemolytic anemia and immune thrombocytopenia. Clinical presentation includes manifestations of immune dysregulation, found in primary immune deficiencies, autoimmune lymphoproliferative ...
A. Fischer   +23 more
core   +3 more sources

Slučaj vodenih kozica s komplikacijom postinfektivne trombocitopenične purpure [PDF]

open access: yes, 2019
Idiopathic thrombocytopenic purpura is a rare but serious complication of chickenpox. The purpose of this report is to describe a case of varicella-related complications of post-infectious idiopathic thrombocytopenic purpura, with a brief review of the ...
Bynda Tetiana Parfenivna   +3 more
core   +2 more sources

Chronic Thromboembolic Pulmonary Hypertension and Antiphospholipid Syndrome with Immune Thrombocytopenia : A Case Report [PDF]

open access: yes, 2018
BACKGROUND Antiphospholipid syndrome is an autoimmune disorder characterized by a hypercoagulable state associated with circulating antiphospholipid antibodies.
Klepetko, Walter   +6 more
core   +1 more source

Immune Thrombocytopenia in a Child with T Cell Lymphoblastic Lymphoma [PDF]

open access: yes, 2016
We describe the case of a 13-year-old boy who presented with persistent thrombocytopenia during maintenance chemotherapy with mercaptopurine and methotrexate for T cell lymphoblastic lymphoma.
Junya Fujimura   +4 more
core   +3 more sources

Púrpura trombocitopênica imunológica como manifestação inicial de lúpus eritematoso sistêmico juvenil Idiopathic thrombocytopenic purpura as initial manifestation of juvenile systemic lupus erythematosus

open access: yesRevista Brasileira de Reumatologia, 2003
Os pacientes com púrpura trombocitopênica imunológica apresentam risco aumentado para desenvolver lúpus eritematoso sistêmico, principalmente quando a doença evolui de forma crônica. Alguns autores observaram que o sexo feminino, a idade mais avançada, a
Josefina Aparecida Pellegrini Braga   +3 more
doaj   +1 more source

Idiopathic Thrombocytopenic Purpura after Mastectomy and Axillary Lymph Node Dissection

open access: yesCase Reports in Surgery, 2014
First described in 1916, idiopathic thrombocytopenic purpura (ITP) is an autoimmune disease resulting in the destruction of platelets. Here, we present a case of an 85-year-old patient diagnosed with invasive ductal carcinoma of the breast whose surgical
Wil L. Santivasi   +2 more
doaj   +1 more source

Purpura with regular shape in an adolescent: Beware of dermatitis artefacta

open access: yesFrontiers in Pediatrics, 2022
BackgroundPurpura is common in pediatric patients, mostly diagnosed as IgA-related vasculitis (Henoch–Schönlein purpura), idiopathic thrombocytopenic purpura (ITP), and thrombotic thrombocytopenic purpura (TTP). However, in some cases, for example, cases
Yuhao Chen   +4 more
doaj   +1 more source

EMERGENCY MANAGEMENT OF CRITICAL BLEEDS IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA: DEVELOPING A NOVEL METHODOLOGY FOR RARE DISEASES GUIDELINES [PDF]

open access: yes, 2022
The day that I joined McMaster University and the Department of Health Research Methods, Evidence, and Impact as a Master student, I did not foresee the amazing journey I was embarking on or the impact of my academic achievements.
Sirotich, Emily
core  

Home - About - Disclaimer - Privacy